公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 BIO-RAD LABORATORIOS BRASIL LTDA取消

227 记录

产品持有公司班级有效性
Geenius HIV 1/2 Confirmatory Assay80020690327BIO-RAD LABORATORIOS BRASIL LTDAIV25/08/2034
Geenius HIV 1/2 Confirmatory Controls80020690328BIO-RAD LABORATORIOS BRASIL LTDAIV01/09/2034
Genscreen HIV 1/2 Versão 280020690044BIO-RAD LABORATORIOS BRASIL LTDAIV21/02/2027
Genscreen Ultra HIV Ag-Ab80020690163BIO-RAD LABORATORIOS BRASIL LTDAIV26/02/2037
HPV Genotype 16 Control80020690435BIO-RAD LABORATORIOS BRASIL LTDAIII29/10/2034
HPV Genotype 18 Control80020690437BIO-RAD LABORATORIOS BRASIL LTDAIII13/01/2035
HPV Genotype 68 Control80020690438BIO-RAD LABORATORIOS BRASIL LTDAIII13/01/2035
HPV Negative Control80020690431BIO-RAD LABORATORIOS BRASIL LTDAIII23/09/2034
Hemoglobin Capillary Collection System (HCCS)80020690283BIO-RAD LABORATORIOS BRASIL LTDAI现有
ID- DiaClon ABO/D + Prova Reversa para Doadores80020690476BIO-RAD LABORATORIOS BRASIL LTDAIV13/05/2028
ID-CARTAO DIACLON ABO/D + PROVA REVERSA80020690467BIO-RAD LABORATORIOS BRASIL LTDAIV30/09/2034
ID-Coombs Anti-IgG80020690463BIO-RAD LABORATORIOS BRASIL LTDAIII06/03/2037
ID-DAT IgG - Dilution80020690462BIO-RAD LABORATORIOS BRASIL LTDAIII06/03/2037
ID-DAT IgG1/IgG380020690454BIO-RAD LABORATORIOS BRASIL LTDAIII06/03/2037
ID-DC Screening I80020690456BIO-RAD LABORATORIOS BRASIL LTDAIII06/03/2037
ID-DC Screening II80020690455BIO-RAD LABORATORIOS BRASIL LTDAIII06/03/2037
ID-DiaClon ABD-Confirmação80020690473BIO-RAD LABORATORIOS BRASIL LTDAIV10/01/2035
ID-DiaClon ABO/D80020690468BIO-RAD LABORATORIOS BRASIL LTDAIV30/10/2034
ID-DiaClon ABO/Rh para Recém-nascidos80020690475BIO-RAD LABORATORIOS BRASIL LTDAIV10/01/2035
ID-LISS/Coombs80020690460BIO-RAD LABORATORIOS BRASIL LTDAIII06/02/2037
IH - 100080020690482BIO-RAD LABORATORIOS BRASIL LTDAII现有
IH-50080020690449BIO-RAD LABORATORIOS BRASIL LTDAII现有
IH-50080020690483BIO-RAD LABORATORIOS BRASIL LTDAII现有
IH-Com80020690443BIO-RAD LABORATORIOS BRASIL LTDAII现有
IH-Com80020690480BIO-RAD LABORATORIOS BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家